Study: CBD and CBG Show Potential in Treating Fatty Liver Disease

Is cannabis a breakthrough cure for fatty liver disease or are the claims premature without human trials?

Published 7 hours ago

Study: CBD and CBG Show Potential in Treating Fatty Liver Disease

story

Above: A close-up view of cannabis leaves was featured at the Asia International Hemp Expo 2025 in Bangkok, Thailand on Sept. 7, 2025. Image credit: Nathalie Jamois/SOPA Images/Getty Images

The Spin

Narrative A

Cannabis compounds CBD and CBG represent a breakthrough treatment for fatty liver disease affecting millions, with laboratory experiments showing these non-psychoactive extracts can reverse fat accumulation and prevent disease development. The medicinal plant has been unjustly stigmatized for decades despite its rich therapeutic qualities, and legal CBD supplements already provide consumers a real alternative for health without requiring full medical cannabis legalization. This research proves natural weight loss therapy from cannabis could become a billion-dollar industry addressing the obesity epidemic.

The Jewish Chronicle The Times of Israel

Narrative B

While preclinical findings on cannabinoid compounds show interesting metabolic effects in laboratory models, clinicians currently lack the clinical trial data necessary to recommend these treatments for fatty liver disease patients. The research remains early-stage and requires substantial additional work, including human trials, toxicology assessments and regulatory approval before any therapeutic application becomes available. Even with promising results, more research is needed on this complex issue.

Mirage News

Dr. Ryan Shelton on Youtube